Carzec-3-125-INT zoom

Hover

Carzec-3-125-INT
Full Screen

Carzec Tablets 3.125mg

CARZEC, a potent antihypertensive agent with a dual mechanism of action. It is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of ≤40% (with or without symptomatic heart failure). With Carzec patient live 1.4 years longer on an average

Category:

Indication

  • In Hypertension (high blood pressure)
  • Angina (hear related chest pain) & Heart Failure

Composition

Each film coated tablet contains : Carvedilol IP 3.125 mg

Direction of use

As advised by your doctor